相关实验视频

Updated: Jan 11, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K

肝脏内胆管癌:肝脏导向治疗是否提供有效的局部疾病控制?

Chad H VanSant-Webb1, Karina C Geranios2, G Weldon Gilcrease3

  • 1Department of Medicine, University of Utah, Salt Lake City, UT, 84112, USA.

American journal of surgery
|November 9, 2025
PubMed
概括

肝脏导向治疗 (LDT) 的结果与肝脏内胆管癌 (iCCA) 的手术切除结果相似. 对于某些ICCA患者来说,LDT可能是最终的局部治疗选择.

关键词:
在肝脏内发生的胆管癌,胆管癌.肝脏指导疗法是指向肝脏的疗法.

更多相关视频

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.8K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

656

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208